Samir Rashmikant Patel

Insider Reports History

Entity
Individual
Location
1111 Main Street, Suite 660, Vancouver, WA
Signature
/s/ Wendy F. DiCicco, as Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Samir Rashmikant Patel:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Akari Therapeutics Plc Director Ordinary Shares, par value $0.0001 per share 5.24B $6.28M $0.00 Dec 2, 2024 PranaBio Investments LLC
Akari Therapeutics Plc Director Warrants (Right to Buy) 419M $503K $0.00 Dec 2, 2024 PranaBio Investments LLC
Akari Therapeutics Plc Director Ordinary Shares, par value $0.0001 per share 91.4M $110K $0.00 Nov 30, 2024 Direct
Akari Therapeutics Plc Director Ordinary Shares, par value $0.0001 per share 3.41B Jun 30, 2024 PranaBio Investments LLC
Akari Therapeutics Plc Director Stock Option (Right to Buy) 163M Nov 30, 2024 Direct
Akari Therapeutics Plc Director Ordinary Shares, par value $0.0001 per share 91.4M Jun 30, 2024 Direct
CytoDyn Inc. Director Non-qualified Stock Option 12.3K Nov 24, 2021 Direct

Insider Reports Filed by Samir Rashmikant Patel

Symbol Company Period Transactions Value $ Form Type Date Filed Role
AKTX Akari Therapeutics Plc Nov 30, 2024 3 $1.01M 4 Dec 3, 2024 Director
AKTX Akari Therapeutics Plc Nov 14, 2024 1 $0 4 Nov 18, 2024 Director
AKTX Akari Therapeutics Plc Oct 31, 2024 1 $0 4 Nov 1, 2024 Director
AKTX Akari Therapeutics Plc Sep 30, 2024 1 $0 4 Oct 2, 2024 Director
AKTX Akari Therapeutics Plc Jun 30, 2024 1 $0 4 Jul 2, 2024 Director
AKTX Akari Therapeutics Plc May 31, 2024 2 $2.39M 4 Jun 4, 2024 Director
AKTX Akari Therapeutics Plc Jan 1, 2024 0 $0 3 Jan 2, 2024 Director
CYDY CytoDyn Inc. Nov 24, 2021 6 $0 4/A Nov 30, 2021 Director
CYDY CytoDyn Inc. Oct 18, 2021 1 $0 4 Oct 20, 2021 Director